Search

everythinglearnresearchcommunity

for

Search:↓

Male hormones affect COVID-19 severity and certain drugs targeting these hormones could help reduce the risk.

The document concludes that various findings in rheumatology offer insights into disease severity, treatment responses, and potential risks in medication, with some limitations due to unspecified participant numbers.

The man's symptoms improved significantly after penicillin treatment for syphilis.

Patients with lupus nephritis and COVID-19 can improve with proper treatment.

A certain genetic variant in the androgen receptor may predict the severity of COVID-19 in men.

Older adults in Vietnam often experience hair loss after COVID-19, especially women, singles, and those hospitalized.

A woman had severe reactions to methotrexate, including skin issues and organ problems, but improved after 38 days in the hospital.

Some patients with hair loss after mild COVID-19 had positive tests for certain autoantibodies.

More people in South Korea are using statins each year, especially those with diabetes, muscle pain, and heart disease, leading to higher medical costs.

The study found that combining different databases gives a better estimate of drug side effects in hospitals.

Azithromycin can rarely cause a severe drop in white blood cells.

Unroofing is an effective, less invasive, and cost-effective surgery for hidradenitis suppurativa with low recurrence and improved patient quality of life.

Tofacitinib is a promising treatment for severe alopecia areata, with many patients experiencing complete or partial hair regrowth.

A young man had vision loss, hair loss, and other symptoms, but tests showed mostly normal results except for slightly high protein in spinal fluid.

Proxalutamide improved recovery, lowered death rates, and reduced hospital stay for COVID-19 patients.

Skin reactions are a common reason for emergency visits due to drug allergies, with some severe cases needing intensive care.

Lamotrigine can cause hair loss.

Passiflora incarnata may help with anxiety and sleep issues but has side effects; teleconsultation for heart failure can improve quality of life; increased screen time for children during the pandemic led to more clinical complaints; older and severely affected COVID-19 patients are more likely to have long-term symptoms.

A patient with Cronkhite-Canada syndrome improved with nutritional support and steroids, but early diagnosis is key due to high mortality.

One in four people still had symptoms like weight loss, hair loss, and fatigue 12-14 weeks after recovering from COVID-19.

COVID-19 may cause temporary hair loss in some people.

Most COVID-19 patients in hospitals have androgenetic alopecia, more in men, suggesting a link between androgen sensitivity and severe COVID-19 symptoms.

Most hospitalized children with skin issues were boys, with allergic skin diseases like atopic dermatitis being most common, and treatments were usually topical.

COVID-19 may cause hair loss and scalp pain due to inflammation and changes in hair follicle receptors, but these symptoms typically resolve in 2 to 4 months.

A 3-year-old with vitamin D-resistant rickets and severe hair loss died despite treatment, highlighting the need for improved management of the condition.

Experts recommend a team-based approach to treat patients with long-lasting COVID-19 symptoms and emphasize the need for ongoing research.

Doctors need to recognize and treat metabolic disorders in children early to prevent serious health issues.

Lupus affects the body and skin, causing joint pain and skin issues that can be treated with steroids and antimalarial drugs.

Pediatric transplant patients often experience unique skin changes mainly due to medication use.

In 2002, various skin reactions were reported due to different drugs, including allergies, hair loss, skin lesions, and other skin conditions.